Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma
Binding of the bromodomain and extraterminal domain proteins (BETs) to acetylated histone residues is critical for gene transcription. We sought to determine the antifibrotic efficacy and potential mechanisms of BET inhibition in systemic sclerosis (SSc). Blockade of BETs was done using a pan-BET in...
Main Authors: | Sirapa Vichaikul, Mikel Gurrea-Rubio, M. Asif Amin, Phillip L. Campbell, Qi Wu, Megan N. Mattichak, William D. Brodie, Pamela J. Palisoc, Mustafa Ali, Sei Muraoka, Jeffrey H. Ruth, Ellen N. Model, Dallas M. Rohraff, Jonatan L. Hervoso, Yang Mao-Draayer, David A. Fox, Dinesh Khanna, Amr H. Sawalha, Pei-Suen Tsou |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2022-05-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.150871 |
Similar Items
-
Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis
by: Pamela J. Palisoc, et al.
Published: (2022-02-01) -
Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy
by: Zhi-Qiang Wang, et al.
Published: (2023-11-01) -
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma
by: Ye Chen, et al.
Published: (2019-03-01) -
A Review of the Bromodomain and Extraterminal Domain Epigenetic Reader Proteins: Function on Virus Infection and Cancer
by: Mengli Wu, et al.
Published: (2024-07-01) -
Prolonged Response of a Patient with Relapsed Acute Myeloid Leukemia to a Novel Oral Bromodomain Extraterminal Inhibitor (BETi)
by: Meilen Chang Muñoz, et al.
Published: (2020-01-01)